protein tyrosine phosphatase 1B inhibitors (Central Drug Research Institute)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Nameprotein tyrosine phosphatase 1B inhibitors (Central Drug Research Institute)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein-tyrosine phosphatase 1B inhibitors
TargetsProtein-tyrosine phosphatase 1B
Therapy Area/IndicationsMetabolic Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndia
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCentral Drug Research Institute
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCentral Drug Research Institute
Active IndicationsN/A
Inactive IndicationsMetabolic Diseases

Other Information

ATC CodeN/A
Related LinksN/A